002399 Shenzhen Hepalink Pharmaceutical Group
- 10.91
- +0.29+2.73%
Shenzhen Hepalink Pharmaceutical Group News
Hyprey: Announcement on the controlling shareholder\'s commitment not to reduce the company\'s share holdings
Hyper Pray: 2022 Annual Equity Allocation Implementation Notice
Hypertherm: 2020 Annual Equity Distribution Implementation Notice
Hypertherm: Announcement on the progress of Mr. Sun Xuan's plan to increase his holdings of the company's H shares
Hypertherm: Announcement on the cancellation of the pledge of the controlling shareholder's shares
Hypertherm: Announcement on the listing and trading of foreign stocks (H shares) listed overseas
Hypertherm: 2019 Annual Equity Distribution Implementation Notice
Hypertherm: Announcement on the controlling shareholder's equity pledge
Hypertherm: Announcement on the cancellation of shareholders\' equity pledge
Hypertherm: 2018 Annual Equity Distribution Implementation Notice
Hypertherm: Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Hypertherm: 2017 Annual Equity Distribution Implementation Notice
Hypertherm: Notice on receipt of the China Securities Regulatory Commission's decision not to approve the company's decision to issue shares to purchase assets
Hypertherm: Issuance of Shares to Purchase Assets and Related Transactions Report (Revised Draft)
Hypertherm: Issuance of Shares to Purchase Assets and Related Transactions Report Summary (Revised Draft)
Hypertherm: Issuance of Shares to Purchase Assets and Related Transactions Report (Revised Draft)
Hypertherm: Issuance of Shares to Purchase Assets and Related Transactions Report (Draft) Summary
Hypertherm: Issuance of Shares to Purchase Assets and Related Transactions Report (Draft)
Hypertherm: Notice on Issuance of Shares to Purchase Assets and Revised Instructions for Related Transactions Report
Hypertherm: Announcement on the progress of the suspension of trading in planning to issue shares to purchase assets
Analysis
Price Target
No Data
No Data